These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26531326)

  • 1. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
    Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
    Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice.
    Hu B; Ye C; Leung EL; Zhu L; Hu H; Zhang Z; Zheng J; Liu H
    Pharmacol Res; 2020 Sep; 159():104942. PubMed ID: 32504835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cranberries attenuate animal-based diet-induced changes in microbiota composition and functionality: a randomized crossover controlled feeding trial.
    Rodríguez-Morató J; Matthan NR; Liu J; de la Torre R; Chen CO
    J Nutr Biochem; 2018 Dec; 62():76-86. PubMed ID: 30269035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota protects from triptolide-induced hepatotoxicity: Key role of propionate and its downstream signalling events.
    Huang JF; Zhao Q; Dai MY; Xiao XR; Zhang T; Zhu WF; Li F
    Pharmacol Res; 2020 May; 155():104752. PubMed ID: 32169656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
    Agus A; Clément K; Sokol H
    Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota, a new frontier to understand traditional Chinese medicines.
    Feng W; Ao H; Peng C; Yan D
    Pharmacol Res; 2019 Apr; 142():176-191. PubMed ID: 30818043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into prebiotic properties on human health: A review.
    Neri-Numa IA; Pastore GM
    Food Res Int; 2020 May; 131():108973. PubMed ID: 32247494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites.
    Ding Y; Yanagi K; Cheng C; Alaniz RC; Lee K; Jayaraman A
    Pharmacol Res; 2019 Mar; 141():521-529. PubMed ID: 30660825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fructans and probiotics on the inhibition of Klebsiella oxytoca and the production of short-chain fatty acids assessed by NMR spectroscopy.
    Higashi B; Mariano TB; de Abreu Filho BA; Gonçalves RAC; de Oliveira AJB
    Carbohydr Polym; 2020 Nov; 248():116832. PubMed ID: 32919546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles.
    Abdul Rahim MBH; Chilloux J; Martinez-Gili L; Neves AL; Myridakis A; Gooderham N; Dumas ME
    Acta Diabetol; 2019 May; 56(5):493-500. PubMed ID: 30903435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Patterns Affect the Gut Microbiome-The Link to Risk of Cardiometabolic Diseases.
    Tindall AM; Petersen KS; Kris-Etherton PM
    J Nutr; 2018 Sep; 148(9):1402-1407. PubMed ID: 30184227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitooligosaccahrides: Digestion characterization and effect of the degree of polymerization on gut microorganisms to manage the metabolome functional diversity in vitro.
    Ji X; Zhu L; Chang K; Zhang R; Chen Y; Yin H; Jin J; Zhao L
    Carbohydr Polym; 2022 Jan; 275():118716. PubMed ID: 34742440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes.
    Guo W; Zhang Z; Li L; Liang X; Wu Y; Wang X; Ma H; Cheng J; Zhang A; Tang P; Wang CZ; Wan JY; Yao H; Yuan CS
    Pharmacol Res; 2022 Aug; 182():106355. PubMed ID: 35842183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
    Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota: a promising target against cardiometabolic diseases.
    Warmbrunn MV; Herrema H; Aron-Wisnewsky J; Soeters MR; Van Raalte DH; Nieuwdorp M
    Expert Rev Endocrinol Metab; 2020 Jan; 15(1):13-27. PubMed ID: 32066294
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbial metabolites as modulators of host physiology.
    Joyce SA; Clarke DJ
    Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.